Table 1 |
||||||
|
Change of measurements on the visual analogue scale 0–10 (VAS) from baseline (day 0) to follow-up (day 70). |
||||||
|
Change of VAS |
Women, no |
Men, no |
||||
|
|
||||||
|
Fatigue |
Muscle |
Neurocogn |
Fatigue |
Muscle |
Neurocogn |
|
|
|
||||||
|
> 2 |
1 |
0 |
2 |
0 |
1 |
0 |
|
|
||||||
|
0.5–2 |
5 |
2 |
1 |
1 |
0 |
2 |
|
|
||||||
|
0 |
1 |
3 |
4 |
2 |
1 |
2 |
|
|
||||||
|
-(0.5–2) |
1 |
4 |
3 |
1 |
1 |
0 |
|
|
||||||
|
< -2 |
2 |
1 |
0 |
1 |
2 |
1 |
|
|
||||||
|
Fatigue = general fatigue, Muscle = muscle symptoms, Neurocogn = neurocognitive symptoms as short-term memory and capacity to concentrate |
||||||
|
Sullivan et al. Nutrition Journal 2009 8:4 doi:10.1186/1475-2891-8-4 |
||||||
